⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
INAB News
IN8bio, Inc. Common Stock
IN8bio Announces Publication in Nature Communications Highlighting Advances in Gamma-Delta T Cell Engineering and Combination Therapies
globenewswire.com
INAB
Form 8-K
sec.gov
INAB
Form 8-K
sec.gov
INAB
IN8bio Reports First Quarter 2026 Financial Results and Recent Business Highlights
globenewswire.com
INAB
IN8bio to Showcase Next-Generation T Cell Engager Platform and New Clinical Data at Upcoming R&D Day and Medical Conferences
globenewswire.com
INAB
RedChip's Biotech Virtual Investor Conference Replays Now Available
accessnewswire.com
INAB
DMAC
NSRX
CLDI
RedChip's April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms
accessnewswire.com
INAB
DMAC
NSRX
CNTB
CLDI
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
INAB
Form 8-K
sec.gov
INAB
IN8bio Reports Fourth Quarter and Full-Year 2025 Financial Results - Highlights Durable Survival Improvements in Glioblastoma, Advancing Pipeline and Strengthened Financial Position for 2026
globenewswire.com
INAB